In vitro antimicrobial resistance of urinary Escherichia coli isolates among U.S. outpatients from 2000 to 2010
about
Fosfomycin: A First-Line Oral Therapy for Acute Uncomplicated CystitisCiprofloxacin resistance in community- and hospital-acquired Escherichia coli urinary tract infections: a systematic review and meta-analysis of observational studiesUrinary tract infections attributed to diverse ExPEC strains in food animals: evidence and data gaps.The Increase in Hospitalizations for Urinary Tract Infections and the Associated Costs in the United States, 1998-2011.Increased resistance of gram-negative urinary pathogens after kidney transplantation.Fosfomycin and Comparator Activity Against Select Enterobacteriaceae, Pseudomonas, and Enterococcus Urinary Tract Infection Isolates from the United States in 2012.Occurrence and sensitivity profile of extended spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary hospital in Southern Brazil.Pathogenesis of human diffusely adhering Escherichia coli expressing Afa/Dr adhesins (Afa/Dr DAEC): current insights and future challengesKlebsiella pneumoniae antimicrobial drug resistance, United States, 1998-2010Nitrofurantoin contraindication in patients with a creatinine clearance below 60 mL/min: looking for the evidence.Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatmentNitrofurantoin revisited: a systematic review and meta-analysis of controlled trials.Effects of knowledge, attitudes, and practices of primary care providers on antibiotic selection, United States.Validation of a High-Throughput Screening Assay for Identification of Adjunctive and Directly Acting Antimicrobials Targeting Carbapenem-Resistant Enterobacteriaceae.Temporal trends and risks factors for antimicrobial resistant Enterobacteriaceae urinary isolates from outpatients in GuadeloupeEffectiveness and safety of nitrofurantoin in outpatient male veterans.Molecular Basis of Acute Cystitis Reveals Susceptibility Genes and Immunotherapeutic Targets.Control of fluoroquinolone resistance through successful regulation, AustraliaClinical Appraisal of Fosfomycin in the Era of Antimicrobial Resistance.Threading the Needle: Small-Molecule Targeting of a Xenobiotic Receptor to Ablate Escherichia coli Polysaccharide Capsule Expression Without Altering Antibiotic Resistance.Fluoroquinolone resistance mechanisms in an Escherichia coli isolate, HUE1, without quinolone resistance-determining region mutationsPredicting Antibiotic Resistance in Urinary Tract Infection Patients with Prior Urine Cultures.Fluoroquinolone-Resistant and Extended-Spectrum β-Lactamase-Producing Escherichia coli Infections in Patients with Pyelonephritis, United States(1).Diagnosis of Urinary Tract Infections in Children.Outpatient Antibiotic Prescribing Practices for Uncomplicated Urinary Tract Infection in Women in the United States, 2002-2011.Risk Factor Analysis of Ciprofloxacin-Resistant and Extended Spectrum Beta-Lactamases Pathogen-Induced Acute Bacterial Prostatitis in Korea.Regional variations in fluoroquinolone non-susceptibility among Escherichia coli bloodstream infections within the Veterans Healthcare Administration.Urinary Tract Infections due to Multidrug-Resistant Enterobacteriaceae: Prevalence and Risk Factors in a Chicago Emergency Department.In Vitro activity of fosfomycin against Escherichia coli isolated from patients with urinary tract infections in Canada as part of the CANWARD surveillance study.Inhibitors of TonB function identified by a high-throughput screen for inhibitors of iron acquisition in uropathogenic Escherichia coli CFT073.β-Lactam antimicrobials: what have you done for me lately?Levofloxacin for the treatment of pyelonephritis.Escherichia coli sequence type 131: epidemiology and challenges in treatment.The yin-yang driving urinary tract infection and how proteomics can enhance research, diagnostics, and treatment.Antimicrobial Resistance of Escherichia coli Urinary Isolates in the Veterans Affairs Health Care System.Prospective cohort study of risk factors for extended-spectrum ß-lactamase-producing Escherichia coli urinary tract infections in elderly patients admitted to hospital.Antimicrobial resistance in eight US hospitals along the US-Mexico border, 2000-2006.Application of Fluoroquinolone Resistance Score in Management of Complicated Urinary Tract InfectionsRisk factors for resistance to ciprofloxacin in community-acquired urinary tract infections due to Escherichia coli in an elderly population.Fecal Colonization with Extended-Spectrum Beta-Lactamase and AmpC-Producing Escherichia coli.
P2860
Q26745740-AC8249A7-15BA-4D1E-9650-E5C39B353749Q26775453-41AF5A17-0923-41C9-A46D-56073275ED2CQ30896253-1E80608F-A67C-4E1B-8BB1-2EA2FF5CC519Q33629319-673B264C-EC1B-411B-A1D3-7B3F9C2706F9Q33706617-BF002ACA-1B0F-4C10-8B31-B1E91350CF82Q33732529-5457F2D1-B72D-4FA0-8526-982901946A3AQ34045623-6AA8CC89-273D-4EB2-B5AC-2D5B78AC6EFCQ34297628-B7F18B19-349A-4CA9-AB0B-AE97678A0478Q34319083-F87B0925-3982-46BC-8585-AF7CBCBF8251Q34323814-902B07B5-41AD-4CA8-AE27-49704D0A1A6EQ34456773-D1DEDD60-2CA5-4891-BB99-C58DC8960076Q34480338-617CB09F-BE86-464F-B845-B0542AF9790FQ34641587-8B7C97E0-2A0E-432E-AA5B-A877F1513EF2Q35979700-32A6D087-1C8A-412B-81C5-D6BB86F07E93Q36061308-F1DD11FD-E707-4E02-8E2B-31F81AEB42C3Q36086067-268ADCDA-88DD-43D1-B20D-1931E07ED5A0Q36161576-4D5AE1DD-0B9E-40D0-B8E4-CF8E95BEC529Q36221182-0EB49A43-20D7-4273-B2A7-C93B9F192DBFQ36290521-F3F69E3E-2176-4490-BBFE-A86CEED6AC9FQ36705848-812A1FF3-BA03-4D13-BEF7-67325356B7D2Q36871802-990FD024-972A-40EB-9E59-ACE6068204AFQ37120046-30DB8349-E778-4246-853C-C87C52F6F079Q37196254-76431048-A7A9-415E-B935-47B6346262DFQ37218571-E8EEF88A-8FC1-466B-BCE4-48034671EE2EQ37305533-466E8356-5A8A-408C-B9DB-A92A7CF7F05DQ37323458-AC06FEC2-0E8F-41B0-AD8C-FE77923FF5A9Q37349628-CE7DA912-1D3B-4AE7-9D61-601532F3A286Q37351384-B7A5119C-0B42-47FC-8DBE-B365DA2C87DFQ37544647-CE2D51F5-274B-4B17-B5D2-E547C1E5C57BQ37613038-E728E673-59DF-4450-9015-777F87BE87F0Q38076453-DC10EDBF-E728-4401-8C58-D64049B0B80AQ38101380-7DBA6813-9E65-4A72-B8E0-ECDA0808005EQ38201515-6374FE9B-26D1-4ECE-92F8-8BC7FE511B1DQ38563209-7A098608-8576-493B-BD9B-B0CF4AFF9DF8Q38963378-D96A22FD-29EB-41B0-A4E1-59F3A326A078Q40066430-E4420642-8A5F-409F-8784-EDBD6FA615A6Q40167989-D809560C-C362-41D4-AA8B-E351A4F7E22EQ40334475-3F9E41D5-C6B0-41AE-AF23-201394FCFF7AQ40531488-AE4B25EC-A516-4C08-AF5C-DA1D13C50582Q40637960-6D36173C-A222-4292-9A05-9A54FBCECC2A
P2860
In vitro antimicrobial resistance of urinary Escherichia coli isolates among U.S. outpatients from 2000 to 2010
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
In vitro antimicrobial resista ...... outpatients from 2000 to 2010
@ast
In vitro antimicrobial resista ...... outpatients from 2000 to 2010
@en
type
label
In vitro antimicrobial resista ...... outpatients from 2000 to 2010
@ast
In vitro antimicrobial resista ...... outpatients from 2000 to 2010
@en
prefLabel
In vitro antimicrobial resista ...... outpatients from 2000 to 2010
@ast
In vitro antimicrobial resista ...... outpatients from 2000 to 2010
@en
P2093
P2860
P356
P1476
In vitro antimicrobial resista ...... outpatients from 2000 to 2010
@en
P2093
Guillermo V Sanchez
James A Karlowsky
Jose M Bordon
Ronald N Master
P2860
P304
P356
10.1128/AAC.06060-11
P407
P577
2012-01-17T00:00:00Z